Validation of Kaihani Score for Gambling Addiction

Diagnostic Ability of Plasma Based Neuromodulatory Cytokine Production (Kaihani Score) in Gambling Addiction

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04648007

Enrollment

Registered

2020-12-01

Start date

2020-12-15

Completion date

2021-03-30

Last updated

2020-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gambling Addiction

Keywords

addiction, BDNF

Brief summary

The Kaihani Score is a blood based means of assessing molecules believed to be associated with gambling addiction. The current clinical trial will assess the Kaihani Score in 3 groups: Group 1: 10 patients with no personal or family problems with gambling as assessed by the PG-YBOCS (obsessions-compulsions scale Yale-Brown (Y-BOCS), adapted for pathological gambling) (PG-YBOCS). Group 2: 10 patients with moderate gambling addiction as assessed by the PG-YBOCS (obsessions-compulsions scale Yale-Brown (Y-BOCS), adapted for pathological gambling) (PG-YBOCS). Group 3: 10 patients with severe gambling addiction as assessed by the PG-YBOCS (obsessions-compulsions scale Yale-Brown (Y-BOCS), adapted for pathological gambling) (PG-YBOCS). The goal of the study is to confirm preliminary efficacy of the Kaihani Score as a blood based means of assessing gambling propensity.

Interventions

DIAGNOSTIC_TESTKaihani Score

Assessment of neuromodulatory chemicals in peripheral blood plasma samples.

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Inclusion criteria

* Patients with a diagnosis of pathological gambling (DSM IV criteria) * First-time consultants. * Without psychotropic treatment or treatment with a stable and unchanged for over a month.

Exclusion criteria

* Pregnant women and patients with hearing disorders * Epilepsy (untreated or poorly balanced) * Focal brain injury, whatever its origin (vascular, traumatic, tumor or infectious) * History of head trauma with loss of consciousness, * Administration of drugs or substances lowering the seizure threshold * Sleep deprivation, jet lag, or drug withdrawal. * Participants with a problem of uncorrected visual acuity. * Other current addiction.

Design outcomes

Primary

Measure	Time frame	Description
Assessment of Kaihani Score	1 Week	Kaihani Score will be compared between non-gamblers, moderate gamblers, and severe gamblers.

Countries

United States

Contacts

Primary ContactWais Kaihani

waiskaihani@gmail.com619 909 2454

Backup ContactThomas Ichim, PhD

thomas.ichim@gmail.com858 353 4303

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026